Avai Bio (AVAI) Capital Expenditures (2019 - 2021)

Avai Bio has disclosed Capital Expenditures across 3 years of filings, most recently posting -$122817.0 for Q1 2021.

• In Q1 2021, Capital Expenditures fell 224.42% year-over-year to -$122817.0; the TTM figure through Mar 2021 stood at $114.0 (down 91.33% YoY), while the FY2021 annual figure was $114.0, down 91.33% from the prior year.
• Capital Expenditures came in at -$122817.0 for Q1 2021 at Avai Bio, down from $122550.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $122550.0 in Q4 2020 to a low of -$122817.0 in Q1 2021.
• Average Capital Expenditures over 3 years is $238.17, with a median of $190.5 recorded in 2020.
• Year-over-year, Capital Expenditures jumped 100.62% in 2020 and slumped 224.42% in 2021.
• Over 3 years, Capital Expenditures stood at -$97400.0 in 2019, then surged by 225.82% to $122550.0 in 2020, then tumbled by 200.22% to -$122817.0 in 2021.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$122817.0 in Q1 2021, $122550.0 in Q4 2020, and $601.0 in Q3 2020.